162 related articles for article (PubMed ID: 34511980)
1. Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.
Chen L; Yang Y; Wang X; Wang C; Lin W; Jiao Z; Wang Z
Pharmgenomics Pers Med; 2021; 14():1093-1106. PubMed ID: 34511980
[TBL] [Abstract][Full Text] [Related]
2. Effect of drug combination on tacrolimus target dose in renal transplant patients with different
Zhang SF; Tang BH; Wei AH; Du Y; Guan ZW; Li Y
Xenobiotica; 2022 Mar; 52(3):312-321. PubMed ID: 35395919
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients.
Du Y; Song W; Xiong X; Ge W; Zhu H
Xenobiotica; 2022 Mar; 52(3):274-283. PubMed ID: 35502774
[TBL] [Abstract][Full Text] [Related]
5. Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule.
Chen X; Wang D; Xu H; Li Z
J Clin Pharm Ther; 2020 Apr; 45(2):309-317. PubMed ID: 31755126
[TBL] [Abstract][Full Text] [Related]
6. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
[TBL] [Abstract][Full Text] [Related]
7. Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule.
Chen X; Wang DD; Xu H; Li ZP
Xenobiotica; 2020 May; 50(5):606-613. PubMed ID: 31530218
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetic study of tacrolimus and
Qu J; Bian R; Liu B; Chen J; Zhai J; Teng F; Guo W; Wei H
Front Pharmacol; 2022; 13():956166. PubMed ID: 36188616
[No Abstract] [Full Text] [Related]
9. Prediction of tacrolimus and Wuzhi tablet pharmacokinetic interaction magnitude in renal transplant recipients.
Chen P; Dai R; She Y; Fu Q; Huang M; Chen X; Wang C
Clin Transplant; 2022 Dec; 36(12):e14807. PubMed ID: 36057787
[TBL] [Abstract][Full Text] [Related]
10. Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study.
Wang DD; Chen X; Li ZP
J Clin Pharm Ther; 2019 Aug; 44(4):611-617. PubMed ID: 30864229
[TBL] [Abstract][Full Text] [Related]
11. Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients.
Cheng F; Li Q; Wang J; Zeng F; Zhang Y
J Clin Pharm Ther; 2021 Dec; 46(6):1636-1649. PubMed ID: 34342024
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of tacrolimus in Chinese adult liver transplant patients.
Teng F; Zhang W; Wang W; Chen J; Liu S; Li M; Li L; Guo W; Wei H
Biopharm Drug Dispos; 2022 Apr; 43(2):76-85. PubMed ID: 35220592
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients.
Cai X; Song H; Jiao Z; Yang H; Zhu M; Wang C; Wei D; Shi L; Wu B; Chen J
Eur J Pharm Sci; 2020 Sep; 152():105448. PubMed ID: 32621968
[TBL] [Abstract][Full Text] [Related]
15. Effect of hepar-protecting Wuzhi capsule on pharmacokinetics and dose-effect character of tacrolimus in healthy volunteers.
Teng F; Wang W; Zhang W; Qu J; Liu B; Chen J; Liu S; Li M; Chen W; Wei H
Biopharm Drug Dispos; 2022 Aug; 43(4):119-129. PubMed ID: 35180322
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
[TBL] [Abstract][Full Text] [Related]
17. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
Andrews LM; Hesselink DA; van Schaik RHN; van Gelder T; de Fijter JW; Lloberas N; Elens L; Moes DJAR; de Winter BCM
Br J Clin Pharmacol; 2019 Mar; 85(3):601-615. PubMed ID: 30552703
[TBL] [Abstract][Full Text] [Related]
18. Wuzhi Tablet (
Li J; Chen S; Qin X; Fu Q; Bi H; Zhang Y; Wang X; Liu L; Wang C; Huang M
Drug Metab Dispos; 2017 Nov; 45(11):1114-1119. PubMed ID: 28864749
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus Population Pharmacokinetic Model in Adult Chinese Patients with Nephrotic Syndrome and Dosing Regimen Identification Using Monte Carlo Simulations.
Liao M; Wang M; Zhu X; Zhao L; Zhao M
Ther Drug Monit; 2022 Oct; 44(5):615-624. PubMed ID: 36101928
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics model and initial dose optimization of tacrolimus in children and adolescents with lupus nephritis based on real-world data.
Chen X; Wang DD; Xu H; Li ZP
Exp Ther Med; 2020 Aug; 20(2):1423-1430. PubMed ID: 32765671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]